Page last updated: 2024-08-16

tyramine and befloxatone

tyramine has been researched along with befloxatone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armand, P; Berlin, I; Caille, P; Durrieu, G; Fitoussi, S; Molinier, P; Patat, A1
Caille, D; Curet, O; Ego, D; Jarreau, FX; Rovei, V1
Adam, R; Bergis, OE; Caille, D; Charieras, T; Fankhauser, C; Gardes, A; Grosset, A; Jarreau, FX; Rovei, V1
Curet, O; Dubruc, C; Durrieu, G; Legangneux, E; Patat, A; Rosenzweig, P; Zieleniuk, I1

Trials

1 trial(s) available for tyramine and befloxatone

ArticleYear
Clinical pharmacology of befloxatone: a brief review.
    Journal of affective disorders, 1998, Volume: 51, Issue:3

    Topics: Adult; Aged; Brain; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Oxazoles; Placebos; Psychomotor Performance; Tyramine

1998

Other Studies

3 other study(ies) available for tyramine and befloxatone

ArticleYear
Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:6

    Topics: Adult; Drug Administration Schedule; Drug Interactions; Humans; Male; Monoamine Oxidase Inhibitors; Oxazoles; Pressoreceptors; Single-Blind Method; Tyramine

1995
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor.
    Journal of neural transmission. Supplementum, 1994, Volume: 41

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Drug Interactions; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Rats; Rats, Sprague-Dawley; Tyramine

1994
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Cholinergic Antagonists; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Oxazoles; Rats; Rats, Sprague-Dawley; Sleep, REM; Swimming; Tyramine

1996